These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 16507052

  • 1. Impact of medical treatments for benign prostatic hyperplasia on sexual function.
    Giuliano F.
    BJU Int; 2006 Apr; 97 Suppl 2():34-8; discussion 44-5. PubMed ID: 16507052
    [Abstract] [Full Text] [Related]

  • 2. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC.
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [Abstract] [Full Text] [Related]

  • 3. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson CC.
    BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
    [Abstract] [Full Text] [Related]

  • 4. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M, Rosenberg MT, Perelman MA.
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [Abstract] [Full Text] [Related]

  • 5. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A, Rosen R, Kuritzky L.
    Int J Impot Res; 2007 Jan; 19(4):386-92. PubMed ID: 17377613
    [Abstract] [Full Text] [Related]

  • 6. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC, Fitzpatrick JM, ALF-LIFE Study Group.
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [Abstract] [Full Text] [Related]

  • 7. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.
    Hellstrom WJ, Sikka SC.
    J Urol; 2006 Oct; 176(4 Pt 1):1529-33. PubMed ID: 16952675
    [Abstract] [Full Text] [Related]

  • 8. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
    Rosen RC, Giuliano F, Carson CC.
    Eur Urol; 2005 Jun; 47(6):824-37. PubMed ID: 15925080
    [Abstract] [Full Text] [Related]

  • 9. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
    Gacci M, Ficarra V, Sebastianelli A, Corona G, Serni S, Shariat SF, Maggi M, Zattoni F, Carini M, Novara G.
    J Sex Med; 2014 Jun; 11(6):1554-66. PubMed ID: 24708055
    [Abstract] [Full Text] [Related]

  • 10. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
    Rosen R, Seftel A, Roehrborn CG.
    Int J Impot Res; 2007 Jun; 19(5):480-5. PubMed ID: 17717526
    [Abstract] [Full Text] [Related]

  • 11. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
    Nickel JC, Elhilali M, Emberton M, Vallancien G, Alf-One Study Group.
    BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
    [Abstract] [Full Text] [Related]

  • 12. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA, McVary KT.
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life.
    Carbone DJ, Hodges S.
    Int J Impot Res; 2003 Aug; 15(4):299-306. PubMed ID: 12934061
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.
    Masumori N, Tsukamoto T, Iwasawa A, Furuya R, Sonoda T, Mori M, Hokkaido Urological Disorders Conference Writing Group.
    Urol Int; 2009 Aug; 83(1):49-54. PubMed ID: 19641359
    [Abstract] [Full Text] [Related]

  • 18. Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
    Gross AJ, Busse M, Leonard J, Schumacher H.
    Prostate Cancer Prostatic Dis; 2005 Aug; 8(3):210-4. PubMed ID: 15883586
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Medical management of benign prostatic hypertrophy.
    Nix JW, Carson CC.
    Can J Urol; 2007 Dec; 14 Suppl 1():53-7. PubMed ID: 18163946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.